Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Update Il y a 4 ans
Reference: NCT00956436

Woman and Man

Extract

This is a phase 1b, open-Label study of sorafenib with BIIB022 in subjects with advanced hepatocellular carcinoma.


Inclusion criteria

  • Hepatocellular carcinoma


Links